|
Over the past two decades I believe that
Low Intensity Laser Therapy has advanced to the point where it
can now be termed “the New Dimension in Medical Practice”. Most
importantly, it has proven to be highly effective in the
treatment of musculoskeletal conditions, arthritis, soft tissue
and sport injuries, wound healing and the treatment of numerous
dermatological conditions and in most of these conditions it can
actually be termed to be the treatment of choice. This
technology has also demonstrated significant and not
infrequently dramatic effects in the treatment of challenging
medical conditions resistant to other conventional and
traditional therapies. These include Crohn’s disease,
Endometriosis, Dementias, Systemic and Neurological disorders.
There are many different therapies
presently being offered to patients. Many of these are not
yet accompanied by solid scientific evidence Most people are
aware that medical lasers first became used in surgery in 1962
but not many know that the initial experimental study on low
intensity laser was performed by Endre Mester, M.D working at
the Semmelwiess Hospital (a most auspicious heritage) in
Budapest, Hungary in 1966.
When I first became interested in low
intensity laser two decades ago it became evident that someone
was going to have to take the time to develop and improve this
technology and to also to determine how to best apply it.
This required the designing and manufacturing of custom laser
systems which led to the creation of Meditech International Inc.
in 1989. Our advances in Low Intensity Laser Therapy since then
have reflected the synergy generated by basic researchers,
different engineering disciplines and the contribution of many
clinicians working together over two decades.
Light energy represents photonic streams
of electron particles which need to be accurately and precisely delivered;
this is a
challenge because there is an almost infinite range of possible
protocol combinations and permutations. The parameters utilized consist of pulse frequency,
duty cycle, wavelength, waveform, duration and other forms of
modulation. The Meditech protocols that have been tailored to
be disease specific. Additionally, customization has allowed for
individualized treatments and settings which have been
determined by extensive clinical experience, to be effective for
many complex and challenging medical conditions.
Meditech manufactures devices for the
professional market as well as for home application thus
allowing for practical long-term maintenance therapy by the
patients at home. For instance, when an arthritic
knee has been treated at the office and requires ongoing
therapy in order to continue cartilaginous regeneration, this
approach brings significant permanent benefit. Moreover,
almost invariably, it eliminates the need for knee replacement.
Our staff at Meditech firmly believe in
“Progress through Education” and because of this practitioners
who wish to utilize our lasers for integration into their
practice, must undergo a three day Certification Course.
Meditech also provides specialized seminars directed to the
treatment of Back Problems, Wound Healing and other topics of
interest on a regular basis. Bi-annually Meditech hosts an
International Conference that brings together a faculty of basic
researchers and clinicians from around the globe.
The corporate headquarters of Meditech
are located in Toronto, Canada along with two Laser Therapy
Clinics. To date, over 2000 systems have been acquired by
hospitals and clinics in 48 countries where some clinics are
being established onsite to to provide immediate therapy for
injured workers as well as those with chronic conditions. The
economic advantages of this approach should be clearly apparent
as there is then only a minimum of lost work time; moreover, operating and insurance costs are reduced
concomitant with the improved physical status of the work-force.
Almost 40% of the patients being treated
at the Meditech Clinics in Toronto suffer from back problems
including disc herniations, multi-level degenerative disc
disease, often accompanied by radiculitis and/or stenosis. Many
have undergone 1, 2 or even 3 previous surgical procedures
without improvement. Some patients obtain dramatic relief after
only 2-3 therapy sessions, whereas in others, persistence and
continuation of treatment (sometimes up to 30 or 40 sessions)
with the appropriate adjustment of protocols is required in
order to achieve optimal clinical outcomes.
Fred Kahn, M.D., F.R.C.S.(C)
Toronto, Ontario, Canada
May 2011
|